Cookies on Pinsent Masons website

Our website uses cookies and similar technologies to allow us to promote our services and enhance your browsing experience. If you continue to use our website you agree to our use of cookies.

To understand more about how we use cookies, or for information on how to change your cookie settings, please see our Cookie Policy.

Life-Lines - Life Sciences through a legal lens

This week we look at a range of topics including the FDA’s proposed review framework for artificial intelligence-based medical devices.

Other highlights in this issue include:

  • Proposed cap on R&D tax credits may adversely affect life sciences SMEs
  • COCIR: advancing cybersecurity of health and digital technologies
  • Commission takes forward its work on ethics guidelines for AI


  • UK government updates plans for no-deal Brexit carbon tax
  • Export of medicines: certificate of a pharmaceutical product in no deal scenario
  • Conditional marketing authorisations, exceptional circumstances marketing authorisations and national scientific advice in a no deal scenario
  • New guidance page on substantial amendments to a clinical trial if the UK leaves the EU with no deal
  • DHSC guidance on prescriptions issued in the EEA and Switzerland
  • No changes to UK right to work checks for EU citizens until 2021


  • Fast-growth companies: their keys to success – Dublin, Wednesday 1 May 2019

Key Contacts